Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by No Intervention

Research Leaders

6 sponsors active, led by Geisinger Clinic

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total

Not Applicable (1)

Trial Status

Completed1

Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials

NCT06238726Not ApplicableCompleted

Nudging Patients to Increase Shingles Vaccination

NCT07141875Not Yet RecruitingPrimary

Child Vaccination Scheduling in China

Showing all 2 trials

Research Network

Common Treatments

No Intervention1
Reminder1

Active Sponsors

Geisinger Clinic1
Massachusetts Institute of Technology1
National Bureau of Economic Research, Inc.1
MSD China Holding Co Ltd1
Peking University1

Vaccination Behavior